| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 503 |
| 1 | MACITENTAN | 302 |
| 2 | SILDENAFIL CITRATE | 265 |
| 3 | TADALAFIL | 213 |
| 4 | TREPROSTINIL | 170 |
| 5 | SILDENAFIL | 162 |
| 6 | AMBRISENTAN | 133 |
| 7 | SILDINAFIL | 103 |
| 8 | BOSENTAN | 98 |
| 9 | RIOCIGUAT | 87 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LIQUID BANDAGE | 1 | 0.3333 |
| 1 | LYSINE, LEUCINE, PHENYLALANINE, VALINE, HISTIDINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, TYROSINE | 1 | 0.0714 |
| 2 | EPOPROSTENOL | 503 | 0.0504 |
| 3 | MACITENTAN | 302 | 0.0084 |
| 4 | EPOPROSTENOL SODIUM | 50 | 0.0083 |
| 5 | RIOCIGUAT | 87 | 0.0053 |
| 6 | SILDINAFIL | 103 | 0.0049 |
| 7 | OXACILLIN SODIUM | 3 | 0.0040 |
| 8 | DOBUTAMINE | 6 | 0.0039 |
| 9 | POTASSIUM IODIDE | 2 | 0.0038 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 630 |
| 1 | Endothelin Receptor Antagonist [EPC] | 436 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 298 |
| 3 | Factor Xa Inhibitor [EPC] | 94 |
| 4 | Soluble Guanylate Cyclase Stimulator [EPC] | 87 |
| 5 | Loop Diuretic [EPC] | 65 |
| 6 | Aldosterone Antagonist [EPC] | 64 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 46 |
| 8 | Corticosteroid [EPC] | 45 |
| 9 | Benzodiazepine [EPC] | 32 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 630 | 0.0080 |
| 1 | Soluble Guanylate Cyclase Stimulator [EPC] | 87 | 0.0053 |
| 2 | Prostacyclin Receptor Agonist [EPC] | 46 | 0.0036 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 298 | 0.0035 |
| 4 | Endothelin Receptor Antagonist [EPC] | 436 | 0.0032 |
| 5 | Antiseptic [EPC] | 3 | 0.0011 |
| 6 | Antihypoglycemic Agent [EPC] | 2 | 0.0011 |
| 7 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 8 | 0.0008 |
| 8 | Vasopressin V2 Receptor Antagonist [EPC] | 5 | 0.0008 |
| 9 | Macrolide Antibacterial [EPC] | 1 | 0.0008 |